Consortium for Functional Glycomics
The Consortium for Functional Glycomics (CFG) is a large research initiative funded in 2001 by a glue grant from the National Institute of General Medical Sciences (NIGMS) to “define paradigms by which protein-carbohydrate interactions mediate cell communication”. To achieve this goal, the CFG studies the functions of:
- the three major classes of mammalian glycan-binding proteins (GBPs): C-type lectin, galectin, and SIGLEC
- immune receptors that bind carbohydrates: CD1, T cell receptor, and anti-carbohydrate antibodies
- GBPs of microorganisms that bind to host cell glycans as receptors.
| Formation | 2001 |
|---|---|
| Purpose | to define paradigms by which protein-carbohydrate interactions mediate cell communication |
| Headquarters | The Scripps Research Institute |
Membership | open to any investigator conducting grant-funded research on glycan-binding proteins or their ligands |
Principal Investigator | James Paulson, Ph.D. |
Budget | funded by a 10-year glue grant from the National Institute of General Medical Sciences, part of the U.S. National Institutes of Health (NIH) |
| Website | http://www.functionalglycomics.org |
The CFG comprises eight core facilities and 500+ participating investigators that work together to develop resources and services and make them available to the scientific community free of charge. The data generated by these resources are captured in databases accessible through the Functional Glycomics Gateway, a web resource maintained through a partnership between the CFG and Nature Publishing Group.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.